NAG-3H-ABA is primarily studied for its potential role in modulating neurological and physiological processes. It is believed to interact with the endocannabinoid system, which plays a key role in regulating mood, pain perception, and inflammation. Researchers are exploring its application in developing therapies for conditions such as chronic pain, anxiety, and neurodegenerative disorders. Additionally, its unique structure suggests it may influence GABAergic signaling, making it a candidate for addressing epilepsy or other seizure-related conditions. Further studies are ongoing to fully understand its mechanisms and therapeutic potential.